Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
New class action for Power Solutions (PSIX) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 5/19/2026
-
CENTREVILLE, Va., and RESTON, Va., April 01, 2026 (GLOBE NEWSWIRE) -- Peer Software, a global leader in file replication, synchronization and collaboration solutions, and Carahsoft Technology Corp.,...
-
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Power Solutions To Contact Him Directly To Discuss Their Options If you...
-
Delray Beach, FL, April 01, 2026 (GLOBE NEWSWIRE) -- The global Circuit Breaker Market size is projected to reach USD 30.32 billion by 2030, from USD 22.70 billion in 2025, at a CAGR of 6.0%...
-
BOISE, Idaho, April 01, 2026 (GLOBE NEWSWIRE) -- Micron Technology, Inc. (Nasdaq:MU), (the "Company" or "Micron") announced today that the previously announced cash tender offers (each, a “Tender...
-
NEW PORT RICHEY, Fla., April 01, 2026 (GLOBE NEWSWIRE) -- Zeo Energy Corp. (Nasdaq: ZEO) (“Zeo,” “Zeo Energy,” or the “Company”), a provider of residential solar and commercial long-duration...
-
Axe Compute signs $12M in enterprise GPU agreements, entering Q2 2026 with $835K in estimated monthly income across 20+ customers.
-
LAS VEGAS and BROADVIEW, Ill., April 01, 2026 (GLOBE NEWSWIRE) -- Central Steel Fabricators, a company of Live Ventures Incorporated (NASDAQ: LIVE), announced that it is supplying structural support...
-
Dublin, April 01, 2026 (GLOBE NEWSWIRE) -- The "Data Center Market Report by Component, Type, Enterprise Size, End User, and Region 2026-2034" has been added to ResearchAndMarkets.com's...
-
BOSTON, April 01, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana”), a biotechnology company developing its lead candidate, intranasal foralumab, a fully human,...